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Abstract 
Data from clinical trials involving human participants  are essential in establishing an 
evidence base about the safety and effectiveness of our treatments. This article describes 
the steps involved in designing and setting up a clinical trial, from establishing the 
research question(s), searching the literature, writing a protocol and gaining the 
necessary approvals. Acquiring some knowledge about how to set up a clinical trial will 
allow the conscientious clinician to use the most relevant information to provide the 
highest possible standards of clinical care for their patients. 
Clinical relevance statement 
Even if a clinician is not, has never been, nor is ever planning to be involved in research, 
they should understand and be able to interpret the data from clinical trials. 
Objectives statement 
The reader should understand the importance of the research question(s) and have some 
knowledge about what should be included in a protocol for a clinical trial. 
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Introduction  
Clinical trials involve observations or interventions undertaken with human participants 
(usually patients) to provide information concerning specific questionsabout the safety 
or effectiveness of treatment.  Laboratory and animal studies might provide some initial 
indications in these areas, however they almost always lack clinical validity and can 
rarely replace clinical data obtained in a scientific manner.1 The evidence derived from ǯ
an evidence-based approach to care (Figure 1). 
There are various designs of study and the most appropriate design depends upon the 
research question to be answered. Current conventional wisdom is that a randomised 
controlled trial (RCT), which attempts to reduce the potential influences of both the 
patient and researcher, is the best design for interventional studies in both medicine and 
dentistry.   There may however be practical, ethical or cost considerations that prevent 
the use of this design. The study of human motivations and behaviour may require a 
qualitative approach but, for the purposes of this article, we will mainly focus on the 
design and setting up of a clinical trial using a quantitative approach. 
A number of organisations can provide guidance on designing, conducting, analysing and 
publishing clinical trials. The first organisation to contact is the local Clinical Research 
Network (CRN), which works closely with both the National Health Service (NHS) and 
Higher Education Institutional Research and Development offices (R & D).  The CRNs are 
funded by the National Institute for Health Research (NIHR), a UK organisation that 
supports research in the NHS.  Applications for money to pay for a clinical trial can be 
developed with the help of the local Clinical Trials Units (CTUs), which have expertise in 
all areas of trial design and management.  
The NIHR has devised an online clinical trial toolkit routemap designed to help 
researchers set up and manage a clinical trial of an investigational medicinal product 
(CTIMP)2.  At first glance they may seem quite complicated, as the regulations involving 
CTIMPs are more stringent than those regulating most orthodontic trials. The routemap 
however does provide good guidance about the many requirements that must be satisfied 
when setting up and running a clinical trial. 
Designing the research question for the clinical trial 
Step 1: Identify a knowledge gap  
The first step for any research project is to decide what question the study is attempting 
to answer. When the question(s) has or have been identified, then it is useful to determine ȋȌǤǮǯ, then ask Ǯhow good was this attemptǯ? 
The NIHR recommends that the development of a clinical trial starts with a systematic 
review of the existing literature.3 A systematic review will provide reliable information 
to justify your research and should help develop your study design.3 Do not worry if the 
research has been carried out before and therefore is not considered innovative. 
Systematic reviews rarely find that there is enough high-quality evidence to answer a 
research question. Almost every area of clinical interest, certainly in dentistry, requires 
confirmation that the original results are reproducible and applicable in a variety of 
settings, with a large number of the target population (generalisable). 
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Step 2: Formulate the research question  
The FINER criteria can be used to help formulate a good research question (see Table 1).4 
Step 3: Focus the research question  
Focusing the question for the clinical trial can be undertaken using the acronym PICO: 
P = Patient, population or problem  
I = Intervention being investigated (e.g. medical, surgical, preventative) 
C = Comparator or control (best proven intervention(s), no intervention, placebo)  
O = Outcome(s) attributable to a specific disease, condition or injury 
Step 4: Decide on the study design 
Clinical trials can have several designs (Figure 2): 
x Observational studies (e.g. cross sectional, cohort, case control); 
x Interventional studies or clinical trials (e.g. randomised controlled trials (RCTs)). 
Observational studies are generally non-interventional, because the researcher is not 
able to influence the treatment or environment in which the study takes place, usually for 
practical or ethical reasons. If an observational study is deemed the most appropriate or 
the only feasible approach, the researcher then needs to decide if data will be collected 
for a group of individuals: 
x At one point in time (e.g. cross-sectional); 
x Over the course of time (e.g. longitudinal); 
x Without an outcome of interest, being divided into subgroups based upon their 
exposure to a potential cause (e.g. cohort study); 
x With an outcome of interest being compared to a suitable control group to determine 
the occurrence/timing of exposure to a potential cause (e.g. case-control).5 
Once this has been decided, the researcher then needs to decide if data will be collected 
retrospectively or prospectively. Prospective data collection generally provides stronger 
evidence, because changes within individuals can be assessed and any loss of data or 
participants from the study can be accounted for.  
A prospective, longitudinal study, with registration and follow-up of all consecutive 
patients who start treatment, is often the best way of collecting information about a new 
technique, particularly when it might not be possible to undertake a randomised 
controlled trial (RCT).  
Interventional studies involve comparing the outcomes in a group of individuals who 
have received a treatment (usually novel or new) with a group who have not received the 
treatment or an alternative (usually the conventional) treatment. The decision about who 
receives the new treatment is either allocated randomly (i.e. by chance) or by a quasi-
random technique, such as alternates (not ideal). This aims to ensure the groups are 
comparable at the start of the trial, with any differences that might influence the outcome 
(e.g. confounders) evenly distributed between the groups. This will depend on the correct 
use of an unpredictable, random allocation order and hiding that sequence until 
assignment, to remove any possible biases of the treating clinician or the patient on 
assignment (i.e. blinding).5 
The theoretical strengths of evidence provided by each type of study design are shown in 
Figures 2 and 3.  Ideally, once selected, the study design should be included in the 
research question, so that it can be easily indexed and identified from electronic 
databases.6 
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Step 5: Eliminate bias 
A bias is a systematic error, or deviation, which could affect the interpretation of the 
results, leading to an over or underestimation of the intervention effect.7 There are 
several sources of potential bias within a clinical trial (Table 2) and these should be 
addressed during the design of the trial.7 
Step 6: Refine the specific objectives and hypotheses of the trial 
Objectives: Questions the trial is designed to answer; 
Hypothesis: Specific question being tested to help meet the objectives of the trial and 
amenable to statistical testing. 
Step 7: Patient and public involvement  
Patient and public involvement (PPI) is an important consideration to confirm that the 
research question is important and relevant to the people it directly affects.  The trial 
should also be practical and feasible. 
Clinical trials protocols 
Writing a formal protocol is helpful for a number of reasons: 
x Provides a step-by-step guide which can account for any problems and concerns (e.g. 
bias and confounding); 
x Essential for obtaining funding and sponsorship, as well as the necessary regulatory 
approvals (e.g. ethical and NHS research and development (R&D) approvals); 
x Should limit the possibility of undeclared changes once the trial has begun and/or 
selective outcome reporting. 
Summary 
This first article has described the steps involved in designing and setting up a clinical 
trial from establishing the research question(s) to searching the literature. A forthcoming 
second article will describe how to write a protocol and gain the necessary approvals for 
a clinical trial  
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Figure captions  
Figure 1: What is evidenced based medicine?  
 
Figure 2: Flow chart of clinical trial study designs 
Strength of evidence is colour coded: High = Green, moderate =orange, low = red 
 
Figure 3: Levels of evidence pyramid  
Strength of evidence is colour coded: High = Green, moderate =yellow/orange, low = red 
Tables  
Table 1: The FINER criteria 
 
Table 2: Sources of bias within a clinical trial 
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Figure 2: Flow chart of clinical trial study designs 
Strength of evidence is colour coded: High = Green, moderate =orange, low = red 
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Figure 3: Levels of evidence pyramid  
Strength of evidence is colour coded: High = Green, moderate =yellow/orange, low = red 
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